COVID-19 vaccines ‘highly effective’ against B1.617.2 variant: UK research Press Trust of India May 23, 2021 PHE said that while the Pfizer/BioNTech vaccine was 88 per cent effective against symptomatic COVID-19 from the B1.617.2 variant…
Two AstraZeneca COVID shots 85-90 per cent effective, says UK real-world analysis Reuters May 21, 2021 Britain has suffered one of the worst death tolls globally from the pandemic, but has also had one of the fastest vaccine…
UK study finds T cells could be enough to defend against COVID-19 Reuters Nov 10, 2020 The study found that no participants with a high T cell response developed symptomatic SARS-CoV-2 infection when researchers…
